Avatrombopag for the treatment of children and adolescents with immune thrombocytopenia (AVA-PED-301): a multicentre, randomised, double-blind, placebo-controlled, phase 3b study
Makaleler > Tam Makale · 2025
Yazarlar: Rachael F Grace, Rachael F Grace, Göksel Leblebisatan, Yeşim AYDINOK, Şule Ünal, John D Grainger, Jessica Zhang, Linda Smallwood, Emily de León, Brian D Jamieson, Rachael F Grace, Rachael F Grace, Göksel Leblebisatan, Yesim Aydinok, Sule Ünal, John D Grainger, Waseem Alhushki, Emma J Astwood, Philip Connor, Elena Donyush, Veronika Dudnyk, Stephanie A Fritch-Lilla, John Grainger, Amanda B Grimes, Peter Hauser, Susanne Holzhauer, Loan B Hsieh, Zeynep Karakas, Gabor Kovacs, Osman Alphan Kupesiz, Andrzej Kurylak, Pawel Laguna, Wojciech Mlynarski, Jayashree Motwani, Gabor Ottoffy, Marlene Pasquet, Olga Plaksina, Nataliia Popova, Melissa J Rose, Jessica Sandham, Corinna L Schultz, Keith Sibson, Brigitte Strahm, Selma Unal, Selin Yakarisik, Mehmet Akif Yesilipek
The Lancet Haematology, Uluslararası, Wos, 2025, cilt 12, ss e494-e504